Dynavax Technologies
(NQ:
DVAX
)
11.03
+0.18 (+1.66%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dynavax Technologies
< Previous
1
2
3
4
5
6
Next >
Uniqure Stock Sees Healthy Price Gain, Ranks Among Top 8%
July 11, 2022
Among its other key ratings, Amsterdam-based gene therapy company Uniqure stock also has a 92 Composite Rating.
Via
Investor's Business Daily
Kezar Life Sciences Stock Shows Rising Market Leadership: Earns 81 RS Rating
July 08, 2022
The Relative Strength (RS) Rating for Kezar Life Sciences stock jumped into a new percentile Friday, with a rise from 78 to 81.
Via
Investor's Business Daily
Apellis Pharmaceuticals Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
July 08, 2022
Apellis Pharmaceuticals stock saw its Relative Strength (RS) Rating upgraded to 85 Friday, up from 79 a day earlier.
Via
Investor's Business Daily
7 Small-Cap Stocks to Buy in July 2022
July 04, 2022
These are the best small-cap stocks to buy for July 2022. ARCH, AVUV, CEIX, COUR, DVAX, FATE, and TENB can make great investments.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
May 12, 2022
Gainers
Via
Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...
Via
Benzinga
110 Biggest Movers From Friday
May 16, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.
Via
Benzinga
56 Stocks Moving In Friday's Mid-Day Session
May 13, 2022
Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to...
Via
Benzinga
Dynavax's Adjuvant-Based Bivalent COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action
May 05, 2022
Via
Benzinga
Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030
April 21, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 21, 2022 – Resistance to antibiotics is a growing concern. About 750,000 people die each year worldwide from...
Via
FinancialNewsMedia
Dynavax Adjuvanted Clover Bio's COVID-19 Vaccine Booster Shows Durable Protection Against Omicron
March 17, 2022
Via
Benzinga
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
March 17, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap: Dynavax Technologies Q4 Earnings
February 28, 2022
Dynavax Technologies (NASDAQ:DVAX) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement....
Via
Benzinga
A Preview Of Dynavax Technologies's Earnings
February 25, 2022
Dynavax Technologies (NASDAQ:DVAX) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Three doses of Valneva's COVID-19 Vaccine Neutralizes Omicron Variant, Lab Study Shows
January 19, 2022
Valneva SE (NASDAQ: VALN) has announced results from an initial laboratory study demonstrating that serum antibodies induced by three doses of Valneva's COVID-19 vaccine...
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
December 29, 2021
Tigress Financial lifted the price target on McDonald's Corporation (NYSE:
Via
Benzinga
Here's Why These 3 COVID-19 Vaccine Stocks Got Crushed This Week
December 03, 2021
These second-tier COVID-19 vaccine players plunged due to fears about the potential impacts of the omicron variant.
Via
The Motley Fool
Exposures
COVID-19
Why Dynavax Stock Is Tumbling Today
December 03, 2021
The biotech stock is being pulled down by the broader market sell-off.
Via
The Motley Fool
Why Are Valneva Shares Trading Higher Today?
November 23, 2021
Valneva SE (NASDAQ: VALN) has signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID...
Via
Benzinga
2 Top Stocks You Can Still Buy for Under $20 a Share
November 12, 2021
These two stocks have more than doubled in 2021, but they still can be bought for under $20 per share.
Via
The Motley Fool
Valneva Shares Soar On Securing EU COVID-19 Vaccine Deal
November 10, 2021
Valneva SE (NASDAQ: VALN) shares jumped more than 20% after winning approval from the European Commission for a deal. Over two years, the Company would supply up...
Via
Benzinga
Exposures
COVID-19
64 Stocks Moving In Friday's Mid-Day Session
November 05, 2021
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the...
Via
Benzinga
92 Biggest Movers From Friday
November 08, 2021
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the...
Via
Benzinga
Why Dynavax Stock Is Falling Today
November 05, 2021
Shares of the vaccine maker are down sharply despite a positive earnings report.
Via
The Motley Fool
Dynavax Technologies (DVAX) Q3 2021 Earnings Call Transcript
November 05, 2021
DVAX earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
28 Stocks Moving in Friday's Pre-Market Session
November 05, 2021
Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 65.8% to $2.14 in pre-market trading after the company announced its ReBoot device has been granted designation as a Breakthrough...
Via
Benzinga
Will Valneva and Dynavax Score With Their Late-to-the-Party COVID Vaccine?
October 29, 2021
There's still a sizable market opportunity, especially in developing nations.
Via
The Motley Fool
Exposures
COVID-19
Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine
October 20, 2021
Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing...
Via
FinancialNewsMedia
Exposures
COVID-19
Why Shares of Dynavax Technologies, Ocugen, and Valneva Are on the Move Today
October 18, 2021
These COVID-19 vaccine developers are all moving in response to strong late-stage results for Valneva's VLA2001.
Via
The Motley Fool
Exposures
COVID-19
Why Are Valneva's Shares Trading Higher Monday Premarket?
October 18, 2021
Valneva SE's (NASDAQ: VALN) COVID-19 vaccine elicits a robust immune response with far fewer side effects than the Oxford/AstraZeneca plc's (NASDAQ: AZN) jab,...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.